Journey Medical (DERM) Operating Leases (2020 - 2025)

Journey Medical has reported Operating Leases for 6 years, with the latest figure at $18000.0 in Q4 2025.

• For the quarter ending Q4 2025, Operating Leases fell 84.75% year-over-year to $18000.0; the trailing twelve-month figure through Dec 2025 stood at $18000.0 (down 84.75% YoY), and the FY2025 full-year result was $18000.0, down 84.75% from the prior year.
• Operating Leases for Q4 2025 stood at $18000.0, down from $44000.0 in the prior quarter.
• The five-year high for Operating Leases was $118000.0 in Q4 2024, with the low at $9000.0 in Q4 2023.
• Historically, Operating Leases has averaged $60090.9 across 5 years, with a median of $59000.0 in 2023.
• Annual changes were most pronounced in 2023 — Operating Leases plunged 91.67% — and 2024, when it soared 1211.11%.
• Journey Medical's Operating Leases stood at $24000.0 in 2021, then surged by 350.0% to $108000.0 in 2022, then sank by 91.67% to $9000.0 in 2023, then soared by 1211.11% to $118000.0 in 2024, then plunged by 84.75% to $18000.0 in 2025.
• The last three Operating Leases figures came in at $18000.0 (Q4 2025), $44000.0 (Q3 2025), and $69000.0 (Q2 2025), per Business Quant data.